3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
2
Testicular Neoplasms
1
Teratoma
1
Seminoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Endodermal Sinus Tumor
1
Desmoid Tumors
1
Carcinoma, Embryonal
1
Interventions
Rituximab
13
Cyclophosphamide
9
Magnetic Resonance Spectroscopy
7
Lenalidomide
7
venetoclax
6
obinutuzumab
5
ibrutinib
5
Specimen Handling
5
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Prednisone
4
CT-P10
4
Biopsy
4
zanubrutinib
3
orelabrutinib
3
Vincristine
3
Mycophenolic Acid
3
Cyclosporine
3
polatuzumab vedotin
2
pirtobrutinib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Doxorubicin
2
Busulfan
2
Bendamustine Hydrochloride
2
voruciclib
1
treosulfan
1
tafasitamab
1
prednylidene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Bleomycin
×
90 days
×
Clear all
No trials found.